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Abstract
Objective: To evaluate feasibility, internal consistency, test–retest reliability, and concurrent and discrim-
inative validity of the Infant and Toddler Quality of Life Questionnaire (ITQOL) for parents of pre-school
children with 12 scales (103-items) covering physical and psychosocial domains and impact of child health
on parents, in comparison with the TNO-AZL Pre-school Children Quality of Life Questionnaire (TAP-
QOL). Methods: Parents of children from a random general population sample (2 months–4 years old;
n = 500) and of an outpatient clinic sample of children with respiratory disease (5 months–5 1
2 years old;
n = 217) were mailed ITQOL and TAPQOL questionnaires; a retest was sent after two weeks. Results:
Feasibility: The response was ‡80% with few missing and non-unique ITQOL-answers (<2%) in both
study populations. Some ITQOL-scales (3–4 scales) showed a ceiling eﬀect (>25% at maximum score).
Internal consistency: All Cronbach’s a >0.70. Test–retest Intraclass Correlation Coeﬃcients (ICCs) were
moderate or adequate (‡0.50; p<0.01) for 10 ITQOL-scales. Validity: ITQOL-scales, with a few excep-
tions, correlated better with predeﬁned parallel TAPQOL scales than with non-parallel scales. Five to eight
ITQOL-scales discriminated clearly between children with few and with many parent-reported chronic
conditions, between children with and without doctor-diagnosed respiratory disease and with a low and a
high parent-reported medical consumption (p<0.05). Conclusions: This study supported the evidence that
the ITQOL is a feasible instrument with adequate psychometric properties. The study provided reference
ITQOL scores for gender/age subgroups. We recommend repeated evaluations of the ITQOL in varied
populations, especially among very young children, including repeated assessments of test–retest charac-
teristics and evaluations of responsiveness to change. We recommend developing and evaluating a short-
ened ITQOL version.
Key words: Asthma, General population, Health-related quality of life, Infant and Toddler Quality of Life
Questionnaire (ITQOL), Pre-school children, Reference/norm scores, Reliability, TNO-AZL Pre-school
Children Quality of Life Questionnaire (TAPQOL), Validity
Introduction
Health-related quality of life, complementary to
clinicalanddevelopmental measuresandmortality,
has become an essential indicator of outcome in
clinical evaluation studies [1], community health
studies[2],andwillﬁnditswayintomedicalpractice
[3, 4]. In pediatrics, reliable and validated measures
are available to describe health status and health-
related quality of life of children comprehensively
Quality of Life Research (2007) 16:445–460   Springer 2006
DOI 10.1007/s11136-006-9134-8[5]. However, few were designed to measure health
of pre-school children; most are intended for
school-age children [5, 6]. Challenges with mea-
surement in pre-school children include ﬁnding
ways to accommodate for rapid changes in chil-
dren’s abilities and roles over time, and wide ranges
for normative growth and development [7]. Fur-
thermore, a rating by proxy, often a parent, is
indispensable for this age group. It is diﬃcult to
assess the adequacy of such proxy ratings that may
be confounded by various factors [8].
We evaluated the Infant and Toddler Quality of
Life Questionnaire (ITQOL), the only available
generic‘proﬁlemeasure’(i.e.with10multi-itemand
2 single-item scales) for health status and health-
related quality of life that was designed for children
as young as 2 months up to 5 years old [9, 10]. This
study is the ﬁrst methodological evaluation of the
ITQOL that is based on evaluations with regard to
infants (<1 year old) as well as toddlers (1–5 years
old) in both a random general population sample
and a clinical sample. Regarding the clinical sample
inthisstudy,childrenbeingtreatedforarespiratory
disease were selected since this is the most prevalent
chronic condition in the age group of pre-school
children, and since a negative impact on health-re-
latedqualityoflifebecauseofrespiratorysymptoms
was expected [11, 12].
The ITQOL, developed by Landgraf, adopts the
WorldHealthOrganization’sdeﬁnitionofhealthas
a state of complete physical, mental and social well-
being and not merely the absence of disease, and
incorporates the results of a review of child health
literature and developmental guidelines used by
pediatricians, and the feed-back of parents during
pilot testing [9]. Next to physical and psychosocial
aspects of child health it covers the impact of child
health problems or handicaps on family life; it is to
be completed by the parents [9, 10]. The ITQOL is
conceptually similar to and has overlapping items
and scales with the Child Health Questionnaire
(CHQ), which is among the most widely used
pediatric health status measures, and has been
cross-culturally validated into 21 languages (32
countries) [13–19].
Other generic measures for pre-school children
are: the one-dimensional Functional Status II-Re-
vised (FSIIR; 0–16 years old) [20], a ‘preference-
based measure’ (suitable for economic evaluations)
called Health Status Classiﬁcation System for Pre-
School Children (HSCS-PS; 2–5 years old) [21, 22],
and two other ‘health proﬁle measures’, i.e. the
Pediatric Quality of Life Inventory (PedsQl; 2–
18 years old) [23], and the TNO-AZL Pre-school
Children Quality of Life Questionnaire (TAPQOL;
1–5 years old) [24]. Of these instruments we chose
the TAPQOL to evaluate the concurrent validity of
the ITQOL, as it is also a ‘health proﬁle measure’,
andastheagerangethatiscoveredbytheTAPQOL
(1–5 years) is closest to the one covered by the IT-
QOL (2 months-5 years) [24].
The study objectives were to assess in a random
general population sample and in a clinical sample
of children with respiratory disease:
(1) ThefeasibilityoftheITQOLasaproxymeasure
of child health and health-related quality of life
(indicators: response rates, completion times,
perceived diﬃculty by parents, missing and
non-unique answers, presence of ﬂoor and
ceiling eﬀects);
(2) The reliability of the ITQOL-scales (internal
consistency and test–retest reliability);
(3) The validity of the ITQOL as judged by com-
parisons of speciﬁc ITQOL scale ratings with
speciﬁc TAPQOL scale ratings of the child’s
health (concurrent validity) as well as by the
ability to discriminatebetween subgroups with/
without self-reported chronic conditions, with
high/low medical consumption and with/with-
out doctor-diagnosed respiratory illness/asth-
ma (discriminative validity).
Methods
Study populations and data collection
General population sample
In 2002, by means of the SPSS random number
generator, a random sample of 500 out of 9022
children aged 2 months–4 years in the general
population of six municipalities allocated to the
service area of ‘Carinova Salland’ (single regional
provider of Well-Child Care for the 0–4 year olds)
were mailed a questionnaire. The parents them-
selves decided if either the father or the mother
should complete the questionnaire. Up to two
reminders were sent; no incentives applied. After
two weeks, the same questionnaire was mailed
again to assess test–retest reliability in a random
446subgroup of 158 parents who had returned the ﬁrst
questionnaire, by applying random numbers gen-
erated by SPSS.
Respiratory illness sample
January 2000 to July 2001, at Erasmus University
Medical Center Rotterdam and HAGA Hospital,
The Hague, the Netherlands, patients were re-
trieved by diagnosis asthma or other disease of
trachea/bronchus (ICD-9 coding system 493 and
519.1, respectively) or the reason for encounter
‘wheezing/cough’ as registered by the prospective
problem oriented patient classiﬁcation system [25].
Eligible patients were maximally 5 years old, vis-
iting the pediatric outpatient or emergency
department with recurrent lower respiratory com-
plaints during at least 3 months within the past
year and being treated with bronchodilators or
corticosteroids as documented in the patient re-
cord [26]. Parents of all eligible patients were asked
to participate (n = 230), and 217 agreed and the
questionnaire was sent. After 10 days and
2 months, reminding letters were sent, the third
reminder was by telephone. After 2 weeks, all
parents who returned the questionnaire were
mailed the same questionnaire again to assess test–
retest reliability.
Infant and Toddler Quality of Life Questionnaire
The ITQOL consists of 103 items (10 multi-item
scales and 2 single-item scales; see Table 1) that
generally refer to the situation during the past
4 weeks. It was translated into Dutch according to
international guidelines, including three indepen-
dent forward and two backward translations [13,
27]. Per scale, the items that have 4, 5 or 6 response
options, were summed up with equal weight per
item (some recoded and/or recalibrated) and
transformed into a 0 (worst possible score) to 100
(best possible score) scale [9, 10, 13, 28]. ITQOL-
scales General behavior and Getting along, and
Change in health are only relevant for children
aged one year and older [9].
TNO-AZL Pre-school Children Quality of Life
Questionnaire (TAPQOL)
The TAPQOL, which is in Dutch originally, con-
sists of 43 items divided over 12 multi-item scales
that cover physical, social, cognitive and emo-
tional functioning domains (see Table 5) [24].
TAPQOL-scales Social functioning, Motor func-
tioning and Communication are only relevant for
children aged 1.5 years and older [24].
Other data
In addition, the questionnaires consisted of items
on standard socio-demographic variables, the
presence of parent-reported current chronic con-
ditions, and presence of wheezing and/or dyspnea
and use of asthma medication during the pre-
ceding four weeks as deﬁned in the ISAAC epi-
demiological measurement instrument [29, 30],
and number of visits to the family physician
during the past 12 months related to health
problems of the child. Furthermore the ques-
tionnaire consisted of an item on the time needed
to complete the ITQOL questionnaire and an
item on the perceived diﬃculty of the ITQOL
questionnaire.
Analysis
Only questionnaires concerning children, of
whom at least one of the parents was born in a
Dutch speaking country, were considered eligible
for analysis; in other cases it is questionable
whether the respondents had adequate mastery of
the Dutch language (questionnaires were in
Dutch).
Feasibility
We evaluated the response rates, ITQOL-ques-
tionnaire completion times, and perceived diﬃ-
culty by the parents, and presence of missing and/
or non-unique answers. We assessed mean scale
scores and score distributions and presence of
ﬂoor and ceiling eﬀects (>25% of the respondents
have the minimal and/or maximal score). Addi-
tionally, mean scores per gender/age subgroup in
the general population sample were evaluated.
Reliability
In both samples, overall and in gender/age sub-
groups, Cronbach’s a was used to evaluate the
internal consistency of scales; ‡0.70 is considered
adequate [31]. We assessed whether (on average)
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448Pearson-r correlation coeﬃcients between the
items and their own scale score (without the item
under consideration) were higher than the corre-
lation coeﬃcients between these items and any
other scale, to evaluate whether the ITQOL-multi-
item scales represent separate domains; the
average Pearson-r correlation coeﬃcients were
calculated by applying Fisher’s z transformations
[32]. Additionally, in both samples, we assessed
scaling success in terms of the percentage of (cor-
rected) item-total correlations with the own scale
being higher than the corresponding item-other
scale correlations (not including the single-item
scale Change in health) [13]. In both samples, test–
retest reliability of the ITQOL-scales was, at the
individual level, assessed by test–retest Intraclass
Correlation Coeﬃcients (ICCs) [33]; ‡0.70 is
considered adequate [34]. At the group level,
test–retest reliability was assessed by two-sided
paired-samples t tests, and by eﬀect sizes:
d ¼ð meant2   meant1Þ=SDt1; 0:20   d<0:50 is
considered small, 0:50   d<0:80 moderate, and
d ‡ 0.80 large [35].
Concurrent validity
In both the general population sample and in the
clinical sample, we evaluated whether speciﬁc IT-
QOL-scales correlated better with their assumed
‘parallel’ TAPQOL scales (see below) than with
any other scale, as measured by Pearson-r corre-
lation coeﬃcients; scales are assumed to be ‘par-
allel’ if they pertain to domains that are considered
identical. We hypothesized relatively high corre-
lation coeﬃcients between the following (‘parallel’)
ITQOL-scale/TAPQOL-scale (in italics) pairs:
Physical functioning-Motor functioning; Tempera-
ment/moods-Problem behavior/Positive mood/
Anxiety; General behavior-Problem behavior;
Getting along-Problem behavior/Social functioning.
Discriminative validity
In both the general population sample and in the
clinical sample separately, we evaluated the ability
of the ITQOL to discriminate between subgroups
of children with no parent-reported chronic con-
ditions (excluding asthma in the clinical sample)
and subgroups with ‡2 parent-reported chronic
conditions. Similarly, in the general population
sample (respectively clinical sample), the ITQOL-
scores in the subgroup with 0 (respectively £3)
physician-visits during the past 12 months were
compared with those in the subgroup with ‡4
(respectively ‡8) visits (Table 6).
Additionally, we compared the ITQOL-scores in
a subgroup of the clinical sample (n = 94; only
children of whom the parents conﬁrmed the pres-
ence of asthma) with ITQOL-scores in a gender/
age-matched subgroup of the general population
sample (n = 188; only children of whom the par-
ents denied the presence of asthma); each clinical
subgroup-child was matched to two general pop-
ulation-children with the same gender/age
(6 months classes).
If the ITQOL has adequate discriminative
validity, we hypothesize that relatively low
ITQOL-scores will occur in subgroups with rela-
tively many conditions and/or visits. Diﬀerences
were evaluated by independent-samples t tests
and by eﬀect sizes (d) that were deﬁned
as d ¼½ Mean (no conditions)   Mean (with
condition) =SD in the conditions-subgroup [35].
All analyses were done in SPSS, Version 11.0.
The Medical Ethical Review Board of Erasmus
MC – University Medical Center Rotterdam
approved this study.
Findings
General population sample
In the general population sample, response was
83.0%; ﬁve questionnaires (1.2%) were not eligible
for analysis (non-Dutch families). Response at the
retest was 75.3% (one not eligible); 115 retest-
questionnaires could be matched to a test-ques-
tionnaire (same child and respondent). Mean
respondent age was 33.1 years (SD 7.1); 97% were
mothers (Table 2). The children ranged from 3 to
46 months of age (mean 24.6; SD 13.8); 50% were
girls; 20% of the children had parent-reported
current asthma-like respiratory illness (Table 2).
One hundred and one ITQOL-items had
<2.0% missing answers; maximum was 6.2%
(scale Getting along, item ‘Appears sorry after
having misbehaved’); ITQOL-items had <0.75%
non-unique answers. Mean reported ITQOL-
completion time was 14 minutes (range 2–60; SD
7.2). Four percent of the respondents considered
449Table 2. Characteristics of the study groups (general population sample n = 410; clinical sample of children with respiratory
disease n = 138)
Variable General population sample Clinical sample (respiratory disease)
Mean (SD)
or Range
n %o f
Participants
Mean (SD)
or Range
n %o f
Participants
Demographic characteristics Parents
Respondent age (years)
Mean (SD) 33.1 (7.0) 33.9 (7.3)
Range 21–46 22–46
Respondent gender
Women 396 96.6 121 87.7
Respondent born in the Netherlands
Yes 403 98.3 120 87.0
Respondent educational level
Elementary school 8 2.0 4 2.9
Secondary education 332 80.9 88 63.8
Higher education/university 70 17.1 46 33.3
Respondent employment
Employed 223 54.4 79 57.2
Homemaker 148 36.1 41 29.7
Unemployed/disabled 39 9.5 18 13.0
Parents sharing household
Yes 401 97.8 121 87.7
Demographic characteristics Children
Age (months)
Mean (SD) 24.0 (12.3) 34.4 (16.4)
Range 3–46 5–65
Gender
Girls 203 49.5 56 40.6
Born in the Netherlands
Yes 406 99.0 134 97.1
Respiratory disease characteristics Children
Parent-reported current asthma
Yes 82 20.0 127 92.0
Wheezing (‡1 period or attack during past 4 weeks)
Yes 66 16.1 49 35.5
Dyspnea (‡1 period or attack during past 4 weeks)
Yes 60 14.6 79 57.2
Use of any asthma medication during past 4 weeks
Yes 58 14.1 90 65.2
Use of inhalation steroids during past 4 weeks
Yes 25 6.1 76 55.1
Other chronic conditions Children
Allergies
Yes 26 6.3 52 37.7
Eczema
Yes 58 14.1 45 32.6
Problems with hearing
Yes 43 10.5 31 22.5
Problems with seeing
Yes 7 1.7 3 2.2
Frequent stomachaches
Yes 16 3.9 24 17.4
Any other parent-reported chronic condition
Yes 21 5.1 10 7.2
450the ITQOL-questionnaire to be diﬃcult/very dif-
ﬁcult; 46% neither diﬃcult nor easy; 50% easy/
very easy.
Clinical sample
In the clinical sample, mailed questionnaire re-
sponse was 79.7%; 35 questionnaires (20.2%) were
not eligible for analysis (non-Dutch families); re-
test-response was 82.6%. We could match 114
retest-questionnaires to a test-questionnaire (same
child and respondent). Mean respondent age was
33.9 years (SD 7.3); 88% were mothers (Table 2).
The children ranged from 5 to 65 months of age
(mean 34.5; SD 16.4); 41% were girls; 92% of
parents conﬁrmed the presence of asthma (see
Table 2 for more information).
ITQOL score distributions
Floor eﬀects were absent (see Methods). In the
general population sample four, and in the clinical
sample three ITQOL-scales showed a ceiling eﬀect
(see Methods) (Table 3). In the general population
sample, two ITQOL-scales (Getting along,
Parental-emotional) showed statistically signiﬁ-
cant diﬀerent scores between boys/girls (p<0.05);
six scales between age-subgroups (p<0.05) (see
Annex A).
Internal consistency of ITQOL-scales
All ITQOL-multi-item scales showed adequate
internal consistency in both samples (as>0.70)
(Table 3). In gender/age-subgroups of the general
population sample and of the clinical sample
(Annex A), generally the internal consistencies of
the ITQOL-scales were adequate, however some
subgroup-as were moderate (0.50–0.70), and one a
concerning a very small subgroup (n = 13) was
only 0.13.
In both samples, all ITQOL-multi-item scales
showed on average higher (corrected) item-own
scale correlation coeﬃcients than item-other-scale
correlation coeﬃcients, and the percentage scaling
success was above 90% for all scales in both
samples except for one ITQOL-scale (Getting
along) in the clinical sample, which supports that
the majority of ITQOL multi-item scales represent
separate domains (Table 3).
Test–retest reliability
In the general population sample, four ITQOL-
scales showed adequate (ICC‡0.70; p<0.01) and
six ITQOL-scales showed moderate test–retest
reliability (ICC 0.50–0.70; p<0.01); only one out
of twelve ITQOL-scales had a mean retest score
that was statistically signiﬁcantly diﬀerent from
the mean test score (p<0.05), but the eﬀect size
was small (d = 0.20) (Table 4). Almost identical
results with regard to test–retest reliability of the
ITQOL-scales were found in the clinical popula-
tion sample (Table 4).
Concurrent validity
Generally, the hypothesized pattern of correlation
coeﬃcients between ITQOL- and TAPQOL-scales
was present, except for ITQOL-scale Physical
functioning that did not correlate well with TAP-
QOL-Motor functioning (Table 5). In the clinical
sample, there were less ‘violations’ of the hypoth-
esized pattern of correlation coeﬃcients (7 ‘viola-
tions’; see Methods) than in the general population
sample (11 ‘violations’) (Table 5).
Discriminative validity
As hypothesized, per comparison between sub-
groups, ﬁve to eight ITQOL-scales resulted in
statistically signiﬁcant lower scores in the sub-
groups with relatively many medical conditions,
respectively physician-visits compared to the sub-
groups with relatively few conditions and/or visits
(p<0.05); the largest eﬀect sizes of score-diﬀer-
ences between contrasted subgroups (d ‡ 0.80)
were found for the ITQOL-scales General health
perceptions and Bodily pain (Table 6).
Discussion
In this ﬁrst evaluation of the ITQOL among chil-
dren as young as 3 months up to 5 1
2 years in a
random general population sample and a clinical
sample of children with respiratory illness, we
established the feasibility of this measure in an
unsupported setting (mailed questionnaire). Our
study supports the internal consistency, the con-
current and discriminative validity of the ITQOL-
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452scales and provides (general population) reference/
norm scores for clinical studies. The results give
rise to some concerns about ceiling eﬀects and
test–retest reliability of scales, requiring further
investigation (see below).
Limitations
The ITQOL was designed for children aged
2 months up to 5 years old. The only currently
available ITQOL evaluation concerns Canadian
3–4 year old children from the general population
and a follow-up of Neonatal Intensive Care [10].
Our general population sample did not include
5 year olds, since 48 months is the maximum age
of children attending the Well-Child Care organi-
zation that sampled the data. Furthermore, we did
invite parents of children aged 2 month old, but
the youngest children in the study were reported to
be 3 months old, at the time the questionnaires
were completed. It turned out that the youngest
eligible patients in the respiratory disease sample
were 5 months old. We recommend additional
ITQOL evaluations, especially in very young
children (2 months–1 year). Since the vast major-
ity of respondents in the actual samples were
mothers, the current results can only be general-
ized to settings with comparable proportions
mothers as respondents.
Another limitation of the study is that we
compared ITQOL scores with TAPQOL scores,
although the TAPQOL was developed and vali-
Table 4. Test–retest reliability of the ITQOL in a random subgroup of the general population sample (n = 115) and in the clinical
sample of children with respiratory illness (n = 114)
ITQOL-scales
(test–retest)
Population Test
n = 115/114
mean (SD)
Retest
n = 115/114
mean (SD)
p-value
(Paired-samples
t test)
a
Eﬀect
size (d)
b
Intra class
correlation
coeﬃcients
Physical functioning General population sample 97 (11) 97 (12) 0.36 )0.02 0.69
c
Respiratory illness 87 (20) 92 (16) 0.00 0.22
d 0.68
c
Growth and
development
General population sample 86 (11) 84 (11) 0.01 )0.20
d 0.67
c
Respiratory illness 82 (14) 81 (12) 0.90 )0.01 0.77
c
Bodily pain General population sample 82 (18) 84 (17) 0.35 0.10 0.42
c
Respiratory illness 79 (19) 78 (18) 0.50 )0.08 0.35
c
Temperament and
moods
General population sample 76 (13) 78 (12) 0.21 0.11 0.58
c
Respiratory illness 72 (12) 74 (12) 0.09 0.14 0.68
c
General behavior General population sample 71 (14) 72 (13) 0.21 0.09 0.82
c
Respiratory illness 73 (14) 72 (16) 0.44 )0.05 0.78
c
Getting along General population sample 71 (9) 72 (9) 0.19 0.11 0.74
c
Respiratory illness 72 (10) 72 (11) 0.87 0.03 0.80
c
General health General population sample 79 (14) 80 (14) 0.17 0.09 0.77
c
Respiratory illness 56 (19) 57 (18) 0.13 0.09 0.80
c
Parental-emotional General population sample 92 (11) 93 (9) 0.08 0.12 0.62
c
Respiratory illness 87 (13) 88 (12) 0.25 0.10 0.59
c
Parental-time General population sample 92 (14) 92 (12) 0.69 0.03 0.50
c
Respiratory illness 88 (16) 87 (16) 0.46 )0.04 0.57
c
Family activities General population sample 85 (15) 87 (14) 0.24 0.10 0.56
c
Respiratory illness na na na na na
Family cohesion General population sample 77 (18) 76 (18) 0.59 )0.04 0.71
c
Respiratory illness 73 (21) 76 (20) 0.18 0.14 0.55
c
Change in health
e General population sample 54 (18) 54 (17) 0.91 0.01 0.01
Respiratory illness 70 (24) 71 (23) 0.63 0.03 0.65
c
aPaired-samples t tests for diﬀerences between the scale scores at the test and at the retest.
bDiﬀerence of the means divided by SD at the ﬁrst measurement [35].
cp<0.01.
dIndicates a small eﬀect ð0:2   d<0:5Þ [35].
eScore of 50 indicates child’s health rating to be about the same now as 1 year ago; 0 much worse now than 1 year ago; 100 much better
now than 1 year ago [9, 13].
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456dated for children at least 1 year old. However,
in the general population sample of this study,
the TAPQOL proved to have adequate psycho-
metric properties in the youngest subgroup
(3–12 months) as well [36].
In our study, we did not assess whether parents
as proxies gave adequate ratings; the child’s
health-related quality of life scores may be aﬀected
by parent-related characteristics next to child-re-
lated, especially child-health-related characteristics
[6, 8]. We propose evaluating the impact of parent-
related characteristics, including ratings of par-
ents’ own health, in proportion to the impact of
child and child-health-related characteristics on
ITQOL scores in future studies.
Feasibility
Despite its length (103 items), the current ITQOL
was well accepted by parents in our study, similar
to the Canadian evaluation [10]. However, in order
to limit respondent burden when the ITQOL is
applied in clinical studies, we strongly recommend
developing and evaluating a short ITQOL version.
Score distributions
Five ITQOL-scales showed a ceiling eﬀect to some
degree in either the general population sample or
the clinical sample, or both. Physical functioning
showed the most profound ceiling [10]. Ceiling
eﬀects were less manifest (but still present) in the
clinical sample than in the general population
sample. Ceiling eﬀects are a common phenome-
non, but restrict the use of a measure to detect
changes and to describe health beyond the average
in relatively healthy populations.
In the general population sample, mean
ITQOL-scale scores showed some statistically sig-
niﬁcant diﬀerences between gender/age subgroups.
We recommend repeated studies, preferably with
larger samples, to assess subgroup diﬀerences. This
will facilitate additional analyses to evaluate to
what extent diﬀerential item functioning (DIF)
explains such gender/age subgroup diﬀerences,
and/or to what extent those diﬀerences reﬂect
‘reality’ [37]. In any case, we recommend the use of
gender/age speciﬁc reference values when com-
parisons are being made between scores in speciﬁc
clinical subgroups and general population (refer-
ence) scores.
Reliability, validity and responsiveness to change
Studies in large, varied samples are needed for
additional assessments of the internal consistency
of ITQOL-scales in gender/age subgroups,
speciﬁcally regarding the very young (<1 year
old). Furthermore, we advice future studies with
larger sample sizes to conduct conﬁrmatory fac-
tor analysis using structural equation modelling
to establish factorial validity of the ITQOL
scales. ITQOL test–retest reliability was accept-
able for the majority of scales in both samples,
but given a low test–retest reliability of some
scales and some score diﬀerences between test
and retest scores, we recommend further assess-
ments in varied populations.
This study supported the concurrent and dis-
criminative validity of the ITQOL in a cross-
sectional design, but responsiveness to change
respectively longitudinal construct validity of the
ITQOL has not been evaluated yet. We recom-
mend doing so in future studies, in particular in
the framework of clinical trials, in the course of
which attention should be given to the optimal
choice of the time speciﬁcation of ITQOL items
(‘during the past 4 weeks’, or ‘past week’, etcet-
era) in applications concerning ﬂuctuating
symptoms, as may be the case in respiratory
disease.
Conclusions
Until now, the ITQOL is the only available mul-
tidimensional quality of life measure developed for
children as young as 2 months up to 5 years old.
This study supported the evidence that the ITQOL
is a feasible instrument with adequate psycho-
metric properties. The study provided reference
ITQOL scores for gender/age subgroups. We rec-
ommend repeated evaluations of the ITQOL in
varied populations, especially among very young
children, including repeated assessments of test–
retest characteristics and evaluations of respon-
siveness to change. We recommend developing and
evaluating a shortened ITQOL version.
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Annex A
Mean scores of the ITQOL-scales and internal consistency of ITQOL-scales per age subgroup (<1, 1–2, 2–3, and 3–4 years old)
and per gender subgroup in the general population sample and in the clinical sample of children with respiratory illness
1. Mean scores in age and gender subgroups of the general population sample
ITQOL-scales Population <1 Year
n =9 2
mean (SD)
1–2 Years
n = 116
mean (SD)
2–3 Years
n = 114
mean (SD)
3–4 Years
n =8 5
mean (SD)
Boys
n = 206
mean (SD)
Girls
n = 203
mean (SD)
Physical functioning General population
sample
93.8 (15.0)
b 98.1 (5.4) 97.5 (11.4) 98.7 (2.9)
b 97.0 (10.9) 97.4 (8.6)
Growth and
development
General population
sample
88.8 (10.4)
a 85.8 (10.9) 85.9 (10.3) 86.0 (10.8) 85.7 (11.0) 87.4 (10.2)
Bodily pain General population
sample
84.2 (16.7) 79.0 (17.6)
b 85.1 (15.4) 87.9 (16.3)
a 84.2 (16.8) 83.5 (16.8)
Temperament/moods General population
sample
81.1 (10.4)
b 76.5 (10.7) 75.3 (10.7)
a 76.8 (9.5) 77.7 (10.6) 76.7 (10.5)
General behavior General population
sample
na 74.7 (12.2) 70.9 (13.5) 72.8 (12.2) 71.8 (14.0) 73.9 (11.0)
Getting along General population
sample
na 71.7 (8.4) 70.5 (9.5) 72.1 (8.4) 70.3 (9.2)
a 72.6 (8.2)
a
General health General population
sample
81.1 (13.3) 77.5 (15.2) 79.4 (14.0) 78.7 (15.5) 78.4 (13.9) 79.7 (15.1)
Parental-emotional General population
sample
94.2 (8.9)
a 92.6 (10.9) 91.3 (10.7) 90.1 (11.0) 91.0 (11.1)
a 93.3 (9.7)
a
Parental-time General population
sample
93.4 (8.1) 92.5 (11.4) 92.8 (10.6) 93.3 (13.5) 92.5 (12.3) 93.5 (9.4)
Family activities General population
sample
86.7 (13.5) 86.0 (13.5) 85.6 (14.0) 86.4 (13.3) 85.7 (13.7) 86.8 (13.4)
Family cohesion General population
sample
79.6 (19.2)
a 76.1 (18.4) 73.6 (18.7) 72.3 (18.7) 74.2 (19.7) 76.5 (17.9)
Change in health General population
sample
na 57.4 (18.4) 54.6 (17.5) 55.9 (18.4) 56.9 (19.2) 55.3 (17.5)
2. Cronbach’s as in age and gender subgroups of the general population and clinical sample
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